180 related articles for article (PubMed ID: 12079443)
1. Is Bacillus Calmette-Guerin revaccination necessary for Japanese children?
Rahman M; Sekimoto M; Hira K; Koyama H; Imanaka Y; Fukui T
Prev Med; 2002 Jul; 35(1):70-7. PubMed ID: 12079443
[TBL] [Abstract][Full Text] [Related]
2. Economic evaluation of universal BCG vaccination of Japanese infants.
Rahman M; Sekimoto M; Takamatsu I; Hira K; Shimbo T; Toyoshima K; Fukui T
Int J Epidemiol; 2001 Apr; 30(2):380-5. PubMed ID: 11369746
[TBL] [Abstract][Full Text] [Related]
3. Making wider use of the world's most widely used vaccine: Bacille Calmette-Guerin revaccination reconsidered.
Dye C
J R Soc Interface; 2013 Oct; 10(87):20130365. PubMed ID: 23904584
[TBL] [Abstract][Full Text] [Related]
4. [Where do we stand with BCG vaccination programme in Japan?].
Mori T
Kekkaku; 2001 Apr; 76(4):385-97. PubMed ID: 11398330
[TBL] [Abstract][Full Text] [Related]
5. Modelling the effect of discontinuing universal Bacillus Calmette-Guérin vaccination in an intermediate tuberculosis burden setting.
Fu H; Lin HH; Hallett TB; Arinaminpathy N
Vaccine; 2018 Sep; 36(39):5902-5909. PubMed ID: 30143270
[TBL] [Abstract][Full Text] [Related]
6. A cost-benefit analysis of BCG revaccination in the Czech Republic.
Pathania VS; Trnka L; Krejbich F; Dye C
Vaccine; 1999 Apr; 17(15-16):1926-35. PubMed ID: 10217591
[TBL] [Abstract][Full Text] [Related]
7. Efficacy of the BCG revaccination programme in a cohort given BCG vaccination at birth in Hong Kong.
Leung CC; Tam CM; Chan SL; Chan-Yeung M; Chan CK; Chang KC
Int J Tuberc Lung Dis; 2001 Aug; 5(8):717-23. PubMed ID: 11495262
[TBL] [Abstract][Full Text] [Related]
8. Economic Evaluation of Selective Neonatal Bacillus Calmette-Guérin Vaccination of High-risk Infants in Ireland.
Teljeur C; Moran PS; Harrington P; Butler K; Corcoran B; O'Donnell J; Usher C; O'Flanagan D; Connolly K; Ryan M
Pediatr Infect Dis J; 2018 Aug; 37(8):759-767. PubMed ID: 29432385
[TBL] [Abstract][Full Text] [Related]
9. A cost-effectiveness analysis of universal versus selective immunization with Mycobacterium bovis bacille Calmette-Guérin in Finland.
Hersh AL; Tala-Heikkilä M; Tala E; Tosteson AN; Fordham von Reyn C
Int J Tuberc Lung Dis; 2003 Jan; 7(1):22-9. PubMed ID: 12701831
[TBL] [Abstract][Full Text] [Related]
10. Health economic evaluation of current vaccination strategies and new vaccines against tuberculosis: a systematic review.
Machlaurin A; Pol SV; Setiawan D; van der Werf TS; Postma MJ
Expert Rev Vaccines; 2019 Sep; 18(9):897-911. PubMed ID: 31369299
[No Abstract] [Full Text] [Related]
11. Evaluation of the BCG revaccination programme of schoolchildren in Finland.
Tala-Heikkila M; Nurmela T; Tala E; Tuominen J
Bull Int Union Tuberc Lung Dis; 1991 Mar; 66(1):57-9. PubMed ID: 1859944
[TBL] [Abstract][Full Text] [Related]
12. BCG vaccination and tuberculosis in Japan.
Rahman M; Takahashi O; Goto M; Fukui T
J Epidemiol; 2003 May; 13(3):127-35. PubMed ID: 12749599
[TBL] [Abstract][Full Text] [Related]
13. Efficacy of BCG vaccination of the newborn: evaluation by a follow-up study of contacts in Bangui.
Lanckriet C; Lévy-Bruhl D; Bingono E; Siopathis RM; Guérin N
Int J Epidemiol; 1995 Oct; 24(5):1042-9. PubMed ID: 8557438
[TBL] [Abstract][Full Text] [Related]
14. Systematic review protocol on Bacillus Calmette-Guerin (BCG) revaccination and protection against tuberculosis.
Mahasha PW; Ndwandwe DE; Mavundza EJ; Shey M; Wiysonge CS
BMJ Open; 2019 Oct; 9(10):e027033. PubMed ID: 31619416
[TBL] [Abstract][Full Text] [Related]
15. Bacillus Calmette-Guérin revaccination questionable with low tuberculosis incidence.
Tala-Heikkilä MM; Tuominen JE; Tala EO
Am J Respir Crit Care Med; 1998 Apr; 157(4 Pt 1):1324-7. PubMed ID: 9563757
[TBL] [Abstract][Full Text] [Related]
16. Cost-benefit analysis of BCG-vaccination in Austria.
Ambrosch F; Klima H; Wiedermann G
Dev Biol Stand; 1979; 43():121-6. PubMed ID: 118066
[TBL] [Abstract][Full Text] [Related]
17. Targeted BCG vaccination against severe tuberculosis in low-prevalence settings: epidemiologic and economic assessment.
Altes HK; Dijkstra F; Lugnèr A; Cobelens F; Wallinga J
Epidemiology; 2009 Jul; 20(4):562-8. PubMed ID: 19295437
[TBL] [Abstract][Full Text] [Related]
18. Revisiting the Chingleput BCG vaccination trial for the impact of BCG revaccination on the incidence of tuberculosis disease.
Velayutham B; Thiruvengadam K; Kumaran PP; Watson B; Rajendran K; Padmapriyadarsini C
Indian J Med Res; 2023; 157(2&3):152-159. PubMed ID: 36124494
[TBL] [Abstract][Full Text] [Related]
19. Effectiveness and cost-effectiveness of first BCG vaccination against tuberculosis in school-age children without previous tuberculin test (BCG-REVAC trial): a cluster-randomised trial.
Pereira SM; Barreto ML; Pilger D; Cruz AA; Sant'Anna C; Hijjar MA; Ichihara MY; Santos AC; Genser B; Rodrigues LC
Lancet Infect Dis; 2012 Apr; 12(4):300-6. PubMed ID: 22071248
[TBL] [Abstract][Full Text] [Related]
20. New tuberculosis vaccines in India: modelling the potential health and economic impacts of adolescent/adult vaccination with M72/AS01
Clark RA; Weerasuriya CK; Portnoy A; Mukandavire C; Quaife M; Bakker R; Scarponi D; Harris RC; Rade K; Mattoo SK; Tumu D; Menzies NA; White RG
BMC Med; 2023 Aug; 21(1):288. PubMed ID: 37542319
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
